NO20091331L - Nitrogenholdige substituerte heterocykler som blodplate ADP reseptorinhibitorer - Google Patents
Nitrogenholdige substituerte heterocykler som blodplate ADP reseptorinhibitorerInfo
- Publication number
- NO20091331L NO20091331L NO20091331A NO20091331A NO20091331L NO 20091331 L NO20091331 L NO 20091331L NO 20091331 A NO20091331 A NO 20091331A NO 20091331 A NO20091331 A NO 20091331A NO 20091331 L NO20091331 L NO 20091331L
- Authority
- NO
- Norway
- Prior art keywords
- nitrogen
- receptor inhibitors
- adp receptor
- platelet adp
- containing substituted
- Prior art date
Links
- 102000007466 Purinergic P2 Receptors Human genes 0.000 title abstract 2
- 108010085249 Purinergic P2 Receptors Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 title 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84632806P | 2006-09-20 | 2006-09-20 | |
| US11/856,616 US7834023B2 (en) | 2006-09-20 | 2007-09-17 | Substituted dihydroquinazolines as platelet ADP receptor inhibitors |
| PCT/US2007/079076 WO2008036843A2 (en) | 2006-09-20 | 2007-09-20 | Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091331L true NO20091331L (no) | 2009-05-20 |
Family
ID=39048759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091331A NO20091331L (no) | 2006-09-20 | 2009-03-31 | Nitrogenholdige substituerte heterocykler som blodplate ADP reseptorinhibitorer |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7834023B2 (pt) |
| EP (1) | EP2094272B1 (pt) |
| JP (1) | JP5266232B2 (pt) |
| KR (1) | KR20090057314A (pt) |
| AU (1) | AU2007299723A1 (pt) |
| BR (1) | BRPI0718444A2 (pt) |
| CA (1) | CA2664411A1 (pt) |
| CO (1) | CO6160324A2 (pt) |
| IL (1) | IL197726A0 (pt) |
| MA (1) | MA30775B1 (pt) |
| MX (1) | MX2009003017A (pt) |
| NO (1) | NO20091331L (pt) |
| NZ (1) | NZ576162A (pt) |
| RU (1) | RU2009114827A (pt) |
| TN (1) | TN2009000091A1 (pt) |
| WO (1) | WO2008036843A2 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100260825A1 (en) * | 2009-04-13 | 2010-10-14 | Nair Madhavan G | Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches |
| JP2014517074A (ja) | 2011-06-24 | 2014-07-17 | アムジエン・インコーポレーテツド | Ｔｒｐｍ８アンタゴニストおよび治療におけるそれらの使用 |
| MY157429A (en) | 2011-06-24 | 2016-06-15 | Amgen Inc | Trpm8 antagonists and their use in treatments |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| US9724351B2 (en) | 2012-08-23 | 2017-08-08 | Alios Biopharma, Inc. | Compounds for the treatment of paramoxyvirus viral infections |
| KR20180019234A (ko) | 2015-06-26 | 2018-02-23 | 다케다 야쿠힌 고교 가부시키가이샤 | 콜린성 무스카린 m1 수용체의 조절제로서의 2,3-디히드로-4h-1,3-벤족사진-4-온 유도체 |
| JP6787913B2 (ja) | 2015-10-20 | 2020-11-18 | 武田薬品工業株式会社 | 複素環化合物 |
| CN117866015A (zh) * | 2018-04-30 | 2024-04-12 | 联合生物科技公司 | 一种临床管理中使用的化合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL135175B2 (en) * | 1983-12-22 | 1985-10-31 | Method of printing of articles made of polyamide fibres | |
| DE19650975A1 (de) * | 1996-12-09 | 1998-06-10 | Basf Ag | Neue heterocyclisch substituierte Benzamide und deren Anwendung |
| WO2000055153A1 (en) | 1999-03-17 | 2000-09-21 | Astrazeneca Ab | Amide derivatives |
| US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
| FR2837201A1 (fr) * | 2002-03-18 | 2003-09-19 | Servier Lab | Nouveaux composes derives de la quinazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2005097276A (ja) * | 2003-08-22 | 2005-04-14 | Takeda Chem Ind Ltd | 縮合ピリミジン誘導体およびその用途 |
| WO2005032488A2 (en) | 2003-10-03 | 2005-04-14 | Portola Pharmaceuticals, Inc. | 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| JP4879745B2 (ja) * | 2003-10-03 | 2012-02-22 | ポートラ ファーマシューティカルズ， インコーポレイテッド | 置換イソキノリノン |
| CA2568756A1 (en) | 2004-06-15 | 2005-12-29 | Astrazeneca Ab | Substituted quinazolones as anti-cancer agents |
| US20070010537A1 (en) * | 2004-08-20 | 2007-01-11 | Kazumasa Hamamura | Fused pyramidine derivative and use thereof |
| NZ554211A (en) | 2004-09-29 | 2010-10-29 | Portola Pharm Inc | Substituted 2H-1,3-Benzoxazin-4(3H)-ones |
| JP2009541310A (ja) | 2006-06-19 | 2009-11-26 | アストラゼネカ・アクチエボラーグ | イソキノリン誘導体およびサイトカイン仲介疾患の阻害剤としてのそれらの使用 |
-
2007
- 2007-09-17 US US11/856,616 patent/US7834023B2/en not_active Expired - Fee Related
- 2007-09-20 BR BRPI0718444-1A2A patent/BRPI0718444A2/pt not_active IP Right Cessation
- 2007-09-20 AU AU2007299723A patent/AU2007299723A1/en not_active Abandoned
- 2007-09-20 MX MX2009003017A patent/MX2009003017A/es active IP Right Grant
- 2007-09-20 JP JP2009529403A patent/JP5266232B2/ja not_active Expired - Fee Related
- 2007-09-20 CA CA002664411A patent/CA2664411A1/en not_active Abandoned
- 2007-09-20 EP EP07842909.9A patent/EP2094272B1/en active Active
- 2007-09-20 KR KR1020097007782A patent/KR20090057314A/ko not_active Withdrawn
- 2007-09-20 NZ NZ576162A patent/NZ576162A/en not_active IP Right Cessation
- 2007-09-20 WO PCT/US2007/079076 patent/WO2008036843A2/en not_active Ceased
- 2007-09-20 RU RU2009114827/15A patent/RU2009114827A/ru not_active Application Discontinuation
-
2009
- 2009-03-19 TN TN2009000091A patent/TN2009000091A1/fr unknown
- 2009-03-19 IL IL197726A patent/IL197726A0/en unknown
- 2009-03-20 CO CO09029291A patent/CO6160324A2/es unknown
- 2009-03-31 NO NO20091331A patent/NO20091331L/no not_active Application Discontinuation
- 2009-04-02 MA MA31756A patent/MA30775B1/fr unknown
-
2010
- 2010-10-26 US US12/912,367 patent/US20110098247A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7834023B2 (en) | 2010-11-16 |
| CA2664411A1 (en) | 2008-03-27 |
| RU2009114827A (ru) | 2010-10-27 |
| TN2009000091A1 (en) | 2010-08-19 |
| US20080132499A1 (en) | 2008-06-05 |
| HK1131058A1 (en) | 2010-01-15 |
| KR20090057314A (ko) | 2009-06-04 |
| JP2010504357A (ja) | 2010-02-12 |
| CO6160324A2 (es) | 2010-05-20 |
| WO2008036843A2 (en) | 2008-03-27 |
| MA30775B1 (fr) | 2009-10-01 |
| IL197726A0 (en) | 2009-12-24 |
| EP2094272A2 (en) | 2009-09-02 |
| WO2008036843A3 (en) | 2008-05-15 |
| JP5266232B2 (ja) | 2013-08-21 |
| EP2094272B1 (en) | 2014-03-26 |
| AU2007299723A1 (en) | 2008-03-27 |
| BRPI0718444A2 (pt) | 2013-11-19 |
| NZ576162A (en) | 2012-03-30 |
| MX2009003017A (es) | 2009-06-08 |
| US20110098247A1 (en) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083923L (no) | Pyrazolkinoloner er potente parp-inhibitorer | |
| EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
| NO20084924L (no) | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer | |
| DK1984345T3 (da) | Benzoxaziner og beslægtede nitrogenholdige heterobicykliske forbindelser, der kan anvendes som mineralcorticoidreceptormodulerende midler | |
| EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
| TW200640867A (en) | Pyridine-3-carboxamide derivatives as CB1 inverse agonists | |
| LTC2091918I2 (lt) | Junginiai ir kompozicijos, kaip proteinkinazės inhibitoriai | |
| CL2008003798A1 (es) | Compuestos derivados de heterobiciclos aromaticos sustituidos, inhibidores de pi3 quinasa; composicion farmaceutica; utiles en el tratamiento de cancer, melanomas, glioblastomas, entre otras enfermedades. | |
| NO20090628L (no) | Pyridizinon derivativater | |
| NO20084912L (no) | Bisykliske derivater som CETP-inhibitorer | |
| WO2008048981A3 (en) | Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions | |
| MA32934B1 (fr) | Combinaisons inhibitrices hsp90 | |
| NO20082191L (no) | Forbindelser | |
| CY1112483T1 (el) | Αγωνιστες gpcr πιπεριδινης | |
| NO20083236L (no) | Trombinreseptorantagonister som profilakse mot komplikasjoner fra cardiopulmonar kirurgi | |
| NO20073859L (no) | Pyrrolopyrazoler, potente kinaseinhibitorer | |
| NO20082209L (no) | Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer | |
| NO20090969L (no) | Sammensetninger og fremgangsmater som anvender anti-CS1 antistoffer for a behandle multippel myeloma | |
| DK1846394T3 (da) | Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer | |
| ATE557023T1 (de) | Piperidinylverbindungen als gpcr-agonisten | |
| DK2078001T3 (da) | Diazepan-acetamidderivater som selektive 11-HSD1-inhibitorer | |
| CL2007000595A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras. | |
| TN2009000091A1 (en) | Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors | |
| TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
| NO20084457L (no) | Tiazolidinderivater som P13 kinaseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |